551 related articles for article (PubMed ID: 8497894)
1. Different patterns of sensitization following renal allograft rejection in an inbred rat strain combination.
Wray DW; Baldwin WM; Sanfilippo F
Transplantation; 1993 May; 55(5):1132-8. PubMed ID: 8497894
[TBL] [Abstract][Full Text] [Related]
2. IgM and IgG alloantibody responses to MHC class I and II following rat renal allograft rejection. Effects of transplantectomy and posttransplantation blood transfusion.
Wray DW; Baldwin WM; Sanfilippo F
Transplantation; 1992 Jan; 53(1):167-74. PubMed ID: 1370736
[TBL] [Abstract][Full Text] [Related]
3. IgG alloantibody responses to donor-specific blood transfusion in different rat strain combinations as a predictor of renal allograft survival.
Wasowska B; Baldwin WM; Sanfilippo F
Transplantation; 1992 Jan; 53(1):175-80. PubMed ID: 1370737
[TBL] [Abstract][Full Text] [Related]
4. Donor-specific cellular immunity in rejecting and long-term-surviving class I-disparate rat renal allograft recipients.
Ruiz P; Fuller J; Sanfilippo F
Transplantation; 1990 Jan; 49(1):175-83. PubMed ID: 2301009
[TBL] [Abstract][Full Text] [Related]
5. The association of enhancement of renal allograft survival by donor-specific blood transfusion with host MHC-linked inhibition of IgG anti-donor class I alloantibody responses.
Wasowska B; Baldwin WM; Howell DN; Sanfilippo F
Transplantation; 1993 Sep; 56(3):672-80. PubMed ID: 7692630
[TBL] [Abstract][Full Text] [Related]
6. Association of donor-specific blood transfusion enhancement of rat renal allografts with accelerated development of antiidiotypic antibodies and reduced alloantibody responses.
Downey WE; Baldwin WM; Sanfilippo F
Transplantation; 1990 Jan; 49(1):160-6. PubMed ID: 2301006
[TBL] [Abstract][Full Text] [Related]
7. Induction of allograft nonresponsiveness after intrathymic inoculation with donor class I allopeptides. I. Correlation of graft survival with antidonor IgG antibody subclasses.
Mhoyan A; Cramer DV; Baquerizo A; Shirwan H
Transplantation; 1997 Dec; 64(12):1665-70. PubMed ID: 9422399
[TBL] [Abstract][Full Text] [Related]
8. Complement contributes to the rejection of complete and class I major histocompatibility complex--incompatible cardiac allografts.
Qian Z; Jakobs FM; Pfaff-Amesse T; Sanfilippo F; Baldwin WM
J Heart Lung Transplant; 1998 May; 17(5):470-8. PubMed ID: 9628565
[TBL] [Abstract][Full Text] [Related]
9. The rejection mechanism of rat pancreaticoduodenal allografts with a class I MHC disparity.
Yamamoto S; Ito T; Nakata S; Nozaki S; Uchikoshi F; Shirakura R; Kamiike W; Miyata M; Matsuda H
Transplantation; 1994 Apr; 57(8):1217-22. PubMed ID: 7909966
[TBL] [Abstract][Full Text] [Related]
10. The contribution of terminal complement components to acute and hyperacute allograft rejection in the rat.
Brauer RB; Baldwin WM; Ibrahim S; Sanfilippo F
Transplantation; 1995 Jan; 59(2):288-93. PubMed ID: 7839453
[TBL] [Abstract][Full Text] [Related]
11. IgM and IgG alloantibody production by splenocytes and deposition in rat renal allografts are decreased by donor-specific blood transfusion.
Baldwin WM; Rhoton K; Sanfilippo F
Transplantation; 1991 Feb; 51(2):481-5. PubMed ID: 1994544
[TBL] [Abstract][Full Text] [Related]
12. Intrathymic immunomodulation in sensitized rat recipients of cardiac allografts: requirements for allorecognition pathways.
Stadlbauer TH; Schaub M; Magee CC; Kupiec-Weglinski JW; Sayegh MH
J Heart Lung Transplant; 2000 Jun; 19(6):566-75. PubMed ID: 10867337
[TBL] [Abstract][Full Text] [Related]
13. Peptides derived from alpha-helices of allogeneic class I major histocompatibility complex antigens are potent inducers of CD4+ and CD8+ T cell and B cell responses after cardiac allograft rejection.
Shirwan H; Leamer M; Wang HK; Makowka L; Cramer DV
Transplantation; 1995 Feb; 59(3):401-10. PubMed ID: 7871571
[TBL] [Abstract][Full Text] [Related]
14. T cell requirements for the rejection of renal allografts bearing an isolated class I MHC disparity.
Gracie JA; Bolton EM; Porteous C; Bradley JA
J Exp Med; 1990 Dec; 172(6):1547-57. PubMed ID: 2258695
[TBL] [Abstract][Full Text] [Related]
15. Induction of allograft nonresponsiveness after intrathymic inoculation with donor class I allopeptides. II. Evidence for persistent chronic rejection despite high levels of donor microchimerism.
Shirwan H; Wu GD; Barwari L; Liu A; Cramer DV
Transplantation; 1997 Dec; 64(12):1671-6. PubMed ID: 9422400
[TBL] [Abstract][Full Text] [Related]
16. Evidence that pretransplant donor blood transfusion prevents rat renal allograft dysfunction but not the in situ cellular alloimmune or morphologic manifestations of rejection.
Ruiz P; Coffman TM; Howell DN; Straznickas J; Scroggs MW; Baldwin WM; Klotman PE; Sanfilippo F
Transplantation; 1988 Jan; 45(1):1-7. PubMed ID: 3276038
[TBL] [Abstract][Full Text] [Related]
17. Indirect T cell allorecognition and alloantibody-mediated rejection of MHC class I-disparate heart grafts.
Pettigrew GJ; Lovegrove E; Bradley JA; Maclean J; Bolton EM
J Immunol; 1998 Aug; 161(3):1292-8. PubMed ID: 9686590
[TBL] [Abstract][Full Text] [Related]
18. Contrasting outcomes of donor-specific blood transfusion: effectiveness against cell-mediated but not antibody-mediated rejection.
Yang CP; Shittu E; McManus B; Wood PJ; Bell EB
Transplantation; 1998 Sep; 66(5):639-45. PubMed ID: 9753346
[TBL] [Abstract][Full Text] [Related]
19. Tolerogenicity of donor major histocompatibility complex-matched skin grafts in previously tolerant Massachusetts general hospital miniature swine.
Weiner J; Scalea J; Ishikawa Y; Okumi M; Griesemer A; Hirakata A; Etter J; Gillon B; Moran S; Shimizu A; Yamada K; Sachs DH
Transplantation; 2012 Dec; 94(12):1192-9. PubMed ID: 23269447
[TBL] [Abstract][Full Text] [Related]
20. The prevention of accelerated cardiac allograft rejection in sensitized recipients after treatment with brequinar sodium.
Yasunaga C; Cramer DV; Chapman FA; Wang HK; Barnett M; Wu GD; Makowka L
Transplantation; 1993 Oct; 56(4):898-904. PubMed ID: 8212214
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
